KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Work In Process (2022 - 2025)

Sarepta Therapeutics has reported Work In Process over the past 4 years, most recently at $892.7 million for Q4 2025.

  • Quarterly results put Work In Process at $892.7 million for Q4 2025, up 46.18% from a year ago — trailing twelve months through Dec 2025 was $892.7 million (up 46.18% YoY), and the annual figure for FY2025 was $892.7 million, up 46.18%.
  • Work In Process for Q4 2025 was $892.7 million at Sarepta Therapeutics, up from $885.4 million in the prior quarter.
  • Over the last five years, Work In Process for SRPT hit a ceiling of $892.7 million in Q4 2025 and a floor of $269.2 million in Q4 2022.
  • Median Work In Process over the past 4 years was $610.7 million (2024), compared with a mean of $610.5 million.
  • Biggest five-year swings in Work In Process: increased 18.3% in 2023 and later skyrocketed 91.77% in 2024.
  • Sarepta Therapeutics' Work In Process stood at $269.2 million in 2022, then rose by 18.3% to $318.5 million in 2023, then skyrocketed by 91.77% to $610.7 million in 2024, then soared by 46.18% to $892.7 million in 2025.
  • The last three reported values for Work In Process were $892.7 million (Q4 2025), $885.4 million (Q3 2025), and $802.9 million (Q2 2025) per Business Quant data.